BEIJING, June 24, 2024 /PRNewswire/ — From June 21 to 23, IMCAS Asia was held in Bangkok, Thailand. Wingderm®, a provider of medical aesthetic devices, has garnered significant attention with its innovative aesthetic solutions.
Wingderm® at IMCAS Asia 2024
Many visitors stopped by Wingderm®’s booth and stayed for valuable insights. Wingderm® members communicated and discussed with peers, industry experts and business representatives from all over the world, introducing the design concepts and positionings of the products, staying current with the latest industry and technology trends, learning the successful experience of many outstanding companies. Through communication with all of them, Wingderm® can design the strategies of R&D and market positioning more accurately.
Throughout the exhibition, Derma Innovation, Wingderm®’s distributor in Thailand, has provided substantial support and assistance. With the local advantages of Derma Innovation, Wingderm® can communicate with visitors more effectively, enhancing their trust and recognition of Wingderm®’s products and services.
At every international exhibition, Wingderm® presents professional products and advanced aesthetic concepts, while also improving the reputation. In the future, Wingderm® will continue to participate in international exhibitions and industry events, and look forward to working with excellent partners to provide high-quality products and services for global beauty seekers.
About Wingderm®
Wingderm® since its establishment in 2016, with the aim of “Aesthetics & Technology, Easy to Achieve”, provides leading and reliable intelligent photoelectric medical aesthetic devices, which have been exported to more than 80 countries, with over 10,000 units installed, recognized for safety and effectiveness by experts and beauty seekers.
For more information visit: https://www.wingderm.com/
ข่าวที่เกี่ยวข้อง
- METiS TechBio, the World’s First Publicly Listed AI-Powered Drug Delivery Company, Debuts on the Hong Kong Stock Exchange, “The SpaceX of Pharmaceuticals” Ushers in a New Era of Biopharmaceuticals
- Join the 2026 SDG Asia Expo to “Shape Our Future” for Sustainability in Asia
- Hi & Fi Asia-China 2026 Enters One-Month Countdown, Connecting Asia’s Food & Health Industry in Shanghai
- MEDIPOST’s CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control
